Lawmakers Press FDA on Getting ALS Therapies to Patients
House lawmakers urged the FDA to be more flexible in reviewing potential therapies for amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases, during a hearing of the House Energy & Commerce Health Subcommittee on Thursday. Members also stressed the need to increase diversity in and improve access to clinical trials. Each year, 50 million people […]
Survey Probes Barriers to Long-Acting Injectable PrEP for MSM
Fear of potential severe side effects may be the greatest barrier to long-acting injectable HIV prevention among men who have sex with men (MSM), followed by out-of-pocket costs, a researcher said. When examining relative importance of perceived barriers to long-acting injectable pre-exposure prophylaxis (PrEP), perceived side effects was the most important, representing 52% of the […]
Potential new CAR-T cell therapy for multiple myeloma
Researchers at Mayo Clinic Cancer Center are studying a potential new chimeric antigen receptor-T cell therapy (CAR-T cell therapy) treatment for multiple myeloma. Their findings were published on Friday, June 24, in The Lancet. “CAR-T cell therapy is a type of immunotherapy that involves harnessing the power of a person’s own immune system by engineering […]